Filing Details
- Accession Number:
- 0001437749-15-016753
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-01 18:53:14
- Reporting Period:
- 2015-08-31
- Filing Date:
- 2015-09-01
- Accepted Time:
- 2015-09-01 18:53:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1003642 | Impax Laboratories Inc | IPXL | Pharmaceutical Preparations (2834) | 650403311 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1245365 | Nigel Fleming | C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-08-31 | 6,166 | $41.02 | 8,200 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-08-31 | 10,000 | $20.30 | 18,200 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-31 | 10,000 | $41.02 | 8,200 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-08-31 | 8,000 | $17.99 | 16,200 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-31 | 8,000 | $41.02 | 8,200 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-08-31 | 5,000 | $20.90 | 13,200 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-31 | 5,000 | $41.02 | 8,200 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-08-31 | 10,000 | $0.00 | 10,000 | $20.30 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-08-31 | 8,000 | $0.00 | 8,000 | $17.99 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-08-31 | 5,000 | $0.00 | 5,000 | $20.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-05-26 | No | 4 | M | Direct | |
| 4,000 | 2023-05-15 | No | 4 | M | Direct | |
| 5,000 | 2022-05-23 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $40.34 to $42.15 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- 100% of the shares subject to the option are fully vested and exercisable.
- Of the 12,000 shares underlying the options, 8,000 of the shares subject to the option are fully vested and exercisable.
Billionaire Hedge Funds
